SE9801852D0 - Method of producing thy A-strains of Vibro cholerae, suck strains and their use - Google Patents

Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Info

Publication number
SE9801852D0
SE9801852D0 SE9801852A SE9801852A SE9801852D0 SE 9801852 D0 SE9801852 D0 SE 9801852D0 SE 9801852 A SE9801852 A SE 9801852A SE 9801852 A SE9801852 A SE 9801852A SE 9801852 D0 SE9801852 D0 SE 9801852D0
Authority
SE
Sweden
Prior art keywords
thy
strain
sup
strains
vibrio cholerae
Prior art date
Application number
SE9801852A
Other languages
English (en)
Swedish (sv)
Inventor
Nils Carlin
Michael Lebens
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Priority to SE9801852A priority Critical patent/SE9801852D0/xx
Publication of SE9801852D0 publication Critical patent/SE9801852D0/xx
Priority to AT99927745T priority patent/ATE474055T1/de
Priority to BRPI9910703-1A priority patent/BR9910703B1/pt
Priority to PL344483A priority patent/PL197450B1/pl
Priority to PCT/EP1999/003509 priority patent/WO1999061634A1/fr
Priority to HU0102310A priority patent/HUP0102310A3/hu
Priority to US09/700,712 priority patent/US7261899B1/en
Priority to EP99927745A priority patent/EP1080211B1/fr
Priority to CA002329255A priority patent/CA2329255C/fr
Priority to AU44999/99A priority patent/AU4499999A/en
Priority to DE69942579T priority patent/DE69942579D1/de
Priority to CZ20004354A priority patent/CZ301662B6/cs
Priority to HK01106347.6A priority patent/HK1037206B/en
Priority to EEP200000686A priority patent/EE05520B1/xx
Priority to DK99927745.2T priority patent/DK1080211T3/da
Priority to RU2000132731/13A priority patent/RU2265657C2/ru
Priority to IS5724A priority patent/IS2904B/is
Priority to NO20005950A priority patent/NO327856B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
SE9801852A 1998-05-26 1998-05-26 Method of producing thy A-strains of Vibro cholerae, suck strains and their use SE9801852D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9801852A SE9801852D0 (sv) 1998-05-26 1998-05-26 Method of producing thy A-strains of Vibro cholerae, suck strains and their use
RU2000132731/13A RU2265657C2 (ru) 1998-05-26 1999-05-21 Экспрессионная система, используемая для получения гомологичного или гетерологичного белка, содержащая стабильный мутантный штамм vibrio cholerae
CA002329255A CA2329255C (fr) 1998-05-26 1999-05-21 Methode de production de souches thy a- de vibrio cholerae, lesdites souches et leur utilisation
DE69942579T DE69942579D1 (de) 1998-05-26 1999-05-21 Verfahren zur herstellung thy-a defiziente vibrio cholerae stämme, solche stämme und deren verwendung
PL344483A PL197450B1 (pl) 1998-05-26 1999-05-21 Sposób wytwarzania szczepu thyA¯ Vibrio cholerae, szczep thyA¯Vibrio cholerae, sekwencja nukleotydowa genu thyA¯Vibrio cholerae, sekwencja nukleotydowa regionu oskrzydlającego 5', sekwencja nukleotydowa regionu oskrzydlającego 3' i szczepionka
PCT/EP1999/003509 WO1999061634A1 (fr) 1998-05-26 1999-05-21 Methode de production de souches thy a- de vibrio cholerae, lesdites souches et leur utilisation
HU0102310A HUP0102310A3 (en) 1998-05-26 1999-05-21 Method of producing thy a-strains of vibrio cholerae, such strains and their use
US09/700,712 US7261899B1 (en) 1998-05-26 1999-05-21 Method of producing thy A-strains of Vibrio cholerae, such strains and their use
EP99927745A EP1080211B1 (fr) 1998-05-26 1999-05-21 METHODE DE PRODUCTION DE SOUCHES $i(THY) A?- DE $i(VIBRIO CHOLERAE), LESDITES SOUCHES ET LEUR UTILISATION
AT99927745T ATE474055T1 (de) 1998-05-26 1999-05-21 Verfahren zur herstellung thy-a defiziente vibrio cholerae stämme, solche stämme und deren verwendung
AU44999/99A AU4499999A (en) 1998-05-26 1999-05-21 Method of producing thy a-strains of vibrio cholerae, such strains and their use
BRPI9910703-1A BR9910703B1 (pt) 1998-05-26 1999-05-21 “CEPA delta THY A DO VIBRIO CHOLERAE, E, VACINA”
CZ20004354A CZ301662B6 (cs) 1998-05-26 1999-05-21 Kmen deltathyA Vibrio cholerae postrádající funkci genu thyA
HK01106347.6A HK1037206B (en) 1998-05-26 1999-05-21 Method of producing thy-a-deficient strains of vibrio cholerae, such strains and their use
EEP200000686A EE05520B1 (et) 1998-05-26 1999-05-21 Vibrio cholerae bakteri delta thyA tüvi
DK99927745.2T DK1080211T3 (da) 1998-05-26 1999-05-21 Fremgangsmåde til fremstilling af thy A-defciente stammer af Vibrio cholerae, sådanne stammer og deres anvendelse
IS5724A IS2904B (is) 1998-05-26 2000-11-23 Aðferð við að framleiða stofna af Vibrio cholerae sem skortir thy A, slíkir stofnar og notkun þeirra
NO20005950A NO327856B1 (no) 1998-05-26 2000-11-24 Δ thy A-stamme av Vibrio cholerae, vaksine omfattende denne og fremgangsmate for a fremstille et protein i Vibrio cholerae.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801852A SE9801852D0 (sv) 1998-05-26 1998-05-26 Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Publications (1)

Publication Number Publication Date
SE9801852D0 true SE9801852D0 (sv) 1998-05-26

Family

ID=20411459

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801852A SE9801852D0 (sv) 1998-05-26 1998-05-26 Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Country Status (17)

Country Link
US (1) US7261899B1 (fr)
EP (1) EP1080211B1 (fr)
AT (1) ATE474055T1 (fr)
AU (1) AU4499999A (fr)
BR (1) BR9910703B1 (fr)
CA (1) CA2329255C (fr)
CZ (1) CZ301662B6 (fr)
DE (1) DE69942579D1 (fr)
DK (1) DK1080211T3 (fr)
EE (1) EE05520B1 (fr)
HU (1) HUP0102310A3 (fr)
IS (1) IS2904B (fr)
NO (1) NO327856B1 (fr)
PL (1) PL197450B1 (fr)
RU (1) RU2265657C2 (fr)
SE (1) SE9801852D0 (fr)
WO (1) WO1999061634A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22661A1 (es) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones Nuevos candidatos vacunales de vibrio cholerae y método de obtención
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use
RU2193598C1 (ru) * 2001-07-26 2002-11-27 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Штамм бактерий vibrio cholerae km 200 - продуцент холерного токсина и токсин - корегулируемых пилей адгезии
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
RU2236455C1 (ru) * 2003-10-27 2004-09-20 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Штамм бактерий vibrio cholerae км 168 - основа для конструирования живых вакцин против диарейных заболеваний, вызываемых патогенными штаммами v. cholerae о139
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system
JP2010088301A (ja) * 2007-02-01 2010-04-22 Ajinomoto Co Inc Ｌ−アミノ酸の製造法
DK3503915T5 (da) * 2016-08-26 2024-09-02 Telesis Bio Inc Genetisk modificerede Vibro natriegen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
GB2177097A (en) 1985-06-18 1987-01-14 Genencor Inc Stable maintenance of nucleic acid in recombinant cells
EP0251579A3 (fr) * 1986-06-24 1989-03-22 Enterovax Research Pty. Ltd. Système de marquage non-antibiotique
US5198343A (en) 1986-08-05 1993-03-30 Transgene, S.A. Method for expressing a heterologous protein in a dapD- mutant of E. coli and the strain obtained
IE892131A1 (en) * 1989-06-30 1991-01-02 Univ Cork Marker genes for genetic manipulation
CA2156191A1 (fr) * 1993-02-22 1994-09-01 Stephen B. Calderwood Antigenes heterologues dans des souches cellulaires vivantes de vaccin
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
MX9703017A (es) * 1994-10-24 1997-10-31 Texas A & M Univ Sys Inmunizacion oral con plantas transgenicas.
US6251866B1 (en) * 1997-08-05 2001-06-26 Watson Laboratories, Inc. Conjugates targeted to the interleukin-2 receptor
CU22661A1 (es) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones Nuevos candidatos vacunales de vibrio cholerae y método de obtención
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Also Published As

Publication number Publication date
US7261899B1 (en) 2007-08-28
AU4499999A (en) 1999-12-13
NO20005950D0 (no) 2000-11-24
DE69942579D1 (de) 2010-08-26
IS2904B (is) 2014-10-15
WO1999061634A1 (fr) 1999-12-02
BR9910703B1 (pt) 2014-10-29
HUP0102310A3 (en) 2003-10-28
CA2329255C (fr) 2009-03-10
CA2329255A1 (fr) 1999-12-02
CZ301662B6 (cs) 2010-05-19
PL344483A1 (en) 2001-11-05
HK1037206A1 (en) 2002-02-01
PL197450B1 (pl) 2008-03-31
EE200000686A (et) 2002-04-15
RU2265657C2 (ru) 2005-12-10
BR9910703A (pt) 2001-01-30
DK1080211T3 (da) 2010-10-18
EP1080211B1 (fr) 2010-07-14
IS5724A (is) 2000-11-23
WO1999061634A9 (fr) 2001-12-13
EP1080211A1 (fr) 2001-03-07
CZ20004354A3 (en) 2001-05-16
HUP0102310A2 (hu) 2001-10-28
NO327856B1 (no) 2009-10-05
NO20005950L (no) 2001-01-25
EE05520B1 (et) 2012-02-15
ATE474055T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
Franz et al. Minos, a new transposable element from Drosophila hydei, is a member of the Tc1-like family of transposons
EP0174367A4 (fr) Hotes et procedes de production de produits recombinants en grandes quantites.
SE9801852D0 (sv) Method of producing thy A-strains of Vibro cholerae, suck strains and their use
EP1364966A3 (fr) Production du facteur de croissance épidermique humain recombinant chez les plants
WO2001038484A3 (fr) Genes de mousse tires de physcomitrella patens, codant des proteines impliquees dans la synthese des acides gras et des lipides polyinsatures
ATE412736T1 (de) Retrovirus aus der hiv-gruppe und dessen verwendung
ATE480624T1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
WO2001075132A3 (fr) Expression et purification de polypeptides authentiques bioactifs issus de plantes
EP0114695B1 (fr) ADN codant pour une séquence d'acides aminés à fonction signal et vecteurs contenant cette séquence
RU2000132731A (ru) Способ получения thy a-штаммов vibro cholerae, такие штаммы и их применение
EP0672150A1 (fr) Levures kluyveromyces modifiees, preparation et utilisation
Kim et al. Requirement for the COOH-terminal pro-sequence in the translocation of aqualysin I across the cytoplasmic membrane in Escherichia coli
RU2143492C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
WO1985004419A1 (fr) Vecteurs d'expression a nombre de reproduction eleve
KR100428998B1 (ko) 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법
Roytrakul et al. A Rapid and Simple Method for Construction and Expression of a Synthetic
EP0494149A1 (fr) Proteases modifiees et leur utilisation dans les denrees alimentaires
EP0592574B1 (fr) Procede de production de proteines recombinantes et cellules hotes utilisees
Revel et al. Production of interferon
WO1997039130A2 (fr) Procede pour exprimer et secreter la keratinase
TH3619B (th) มิวแตนท์ของ วิบริโอ คอเลอรี ที่ไม่มีพิษ
Monahan A Review of the Basic Elements of Recombinant DNA Research
TH2022A (th) มิวแตนท์ของ วิบริโอ คอเลอรี ที่ไม่มีพิษ
Kitano et al. DNA coding for alkaline protease
MXPA00011604A (en) Method of producing thy